Venn Life Sciences Holdings Plc (“Venn” or the “Company”) Acquisition of Minority Interest 23 January 2018 Venn Life Sciences Holdings PLC (“VLS”), today announces that it has reached agreement with… read more →
If you are looking for a role with a dynamic company in Drug Development we are currently looking for candidates in Biostatistics, Finance, Pharmacology, Regulatory & Quality. Click on our… read more →
The Venn team are currently manning the stand at the RARE conference in Paris which focuses on the importance of highlighting awareness of Rare Diseases. Venn has excellent experience in… read more →
Our teams have had a busy week attending the Orphan Word Drug Congress and the European Bioanalysis Forum which both took place in Barcelona. Next Monday and Tuesday 20-21 November,… read more →